Fisher Asset Management LLC lowered its position in shares of Core Laboratories Inc. (NYSE:CLB – Free Report) by 14.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 867,726 shares of the oil and gas company’s stock after selling 143,838 shares during the quarter. Fisher Asset Management LLC owned 1.85% of Core Laboratories worth $9,996,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Public Sector Pension Investment Board lifted its position in shares of Core Laboratories by 26.9% in the first quarter. Public Sector Pension Investment Board now owns 148,476 shares of the oil and gas company’s stock valued at $2,226,000 after acquiring an additional 31,485 shares in the last quarter. Envestnet Asset Management Inc. raised its stake in Core Laboratories by 11.4% during the 2nd quarter. Envestnet Asset Management Inc. now owns 282,871 shares of the oil and gas company’s stock valued at $3,259,000 after purchasing an additional 28,866 shares during the period. Trexquant Investment LP lifted its holdings in Core Laboratories by 24.4% in the 1st quarter. Trexquant Investment LP now owns 128,037 shares of the oil and gas company’s stock worth $1,919,000 after purchasing an additional 25,086 shares in the last quarter. QSV Equity Investors LLC boosted its stake in Core Laboratories by 49.3% in the 1st quarter. QSV Equity Investors LLC now owns 88,455 shares of the oil and gas company’s stock worth $1,326,000 after purchasing an additional 29,197 shares during the period. Finally, Nuveen LLC purchased a new stake in Core Laboratories during the 1st quarter valued at approximately $2,573,000. 97.81% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research firms have recently commented on CLB. Zacks Research raised shares of Core Laboratories from a “strong sell” rating to a “hold” rating in a report on Friday, August 15th. Weiss Ratings reissued a “hold (c)” rating on shares of Core Laboratories in a report on Monday. Four research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $12.50.
Core Laboratories Trading Up 4.4%
Shares of CLB opened at $16.43 on Thursday. The stock has a market capitalization of $764.89 million, a PE ratio of 24.52, a P/E/G ratio of 14.37 and a beta of 1.08. The company’s fifty day moving average is $14.10 and its 200 day moving average is $12.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 2.37. Core Laboratories Inc. has a fifty-two week low of $9.72 and a fifty-two week high of $20.82.
Core Laboratories (NYSE:CLB – Get Free Report) last issued its quarterly earnings data on Wednesday, October 22nd. The oil and gas company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.03. Core Laboratories had a net margin of 6.21% and a return on equity of 12.85%. The business had revenue of $134.52 million during the quarter, compared to analysts’ expectations of $130.92 million. During the same period last year, the company posted $0.25 EPS. The business’s revenue was up .1% on a year-over-year basis. Core Laboratories has set its Q4 2025 guidance at 0.180-0.22 EPS. Sell-side analysts expect that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.
Core Laboratories Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, November 24th. Shareholders of record on Monday, November 3rd were given a dividend of $0.01 per share. The ex-dividend date was Monday, November 3rd. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. Core Laboratories’s dividend payout ratio is 5.97%.
Core Laboratories Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
See Also
- Five stocks we like better than Core Laboratories
- When to Sell a Stock for Profit or Loss
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- Do ETFs Pay Dividends? What You Need to Know
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- Differences Between Momentum Investing and Long Term Investing
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
